Skip to main content

Table 2 Type of drugs used/injected by participants in focus group discussion of barriers and motivators to participation and retention in a cohort study in Iran, 2016

From: Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran

Type of drugs Any drug usedc, n (%) Any drug injected, n (%) Main drug used/injected in the past 6 months, n (%)
In the past 6 months In the past 1 month In the past 6 months In the past 1 month Usedc Injected
Heroin/Crack 26 (86.7) 24 (80.0) 29 (96.7) 22 (73.3) 23 (76.7) 27 (90.0)
Methamphetamine 23 (76.7) 18 (60.0) 0 0 2 (6.7) 0
Methadonea 16 (53.3) 9 (30.0) 1 (3.3) 0 2 (6.7) 1 (3.3)
Sedative drugs 15 (50.0) 6 (20.0) 0 0 0 0
Codeine 10 (33.3) 4 (13.3) 0 0 0 0
Opium/Opium extracts 8 (26.7) 2 (6.7) 2 (6.7) 2 (6.7) 1 (3.3) 1 (3.3)
Hashish/Marijuana 6 (20.0) 1 (3.3) 0 0 0 0
Nass (powdered tobacco) 6 (20.0) 5 (16.7) 0 0 0 0
Alcohol 3 (10.0) 0 0 0 1 (3.3) 0
Norjizak/Tamjizakb 2 (6.7) 2 (6.7) 1 (3.3) 0 1 (3.3) 1 (3.3)
Tramadol 2 (6.7) 2 (6.7) 0 0 0 0
Cocaine 1 (3.3) 0 0 0 0 0
Ritalin 1 (3.3) 1 (3.3) 0 0 0 0
Ecstasy (X) 0 0 0 0 0 0
LSD/Acid 0 0 0 0 0 0
Glue 0 0 0 0 0 0
Others (not specified) 1 (3.3) 0 1 (3.3) 0 0 0
  1. a Non-prescription use
  2. b Norjizak/tamjizak is a narcotic drug mostly used through injection and is produced by a combination of different opioids, steroids, and benzodiazepines
  3. c Including injecting and non-injecting drugs